Tianxiangdan (TXD) alleviates myocardial ischemia reperfusion-induced ferroptosis through the activation of estrogen receptor alpha (ERα)

Abstract

Tianxiangdan (TXD), a traditional Chinese herbal remedy, demonstrates efficacy in mitigating myocardial ischemia-reperfusion (I/R)-induced damage. This study employed network pharmacology to evaluate the therapeutic targets and mechanisms of TXD in treating I/R. High-performance liquid chromatography-mass spectrometry (HPLC-MS) identified 86 compounds in TXD. Network pharmacological analysis predicted potential target genes and their modes of action. Cardiac function, ischaemic ST changes, lactate dehydrogenase (LDH), malondialdehyde (MDA), superoxide dismutase (SOD) activity, myocardial fiber, and infarct size were assessed using in vivo and in vitro I/R injury models. Estrogen receptor alpha (ERα) protein expression and estradiol (E2) levels were measured to confirm TXD’s impact on estrogen levels and ERα expression. To examine if TXD reduces I/R injury through ERα, an AZD group (300 nmol·L⁻¹ AZD9496 and 15% TXD serum) was compared to a TXD group (15% TXD serum). The study hypothesized that TXD upregulates the ERα-mediated iron metamorphosis pathway. I/R injury-induced ferroptosis was identified using a Fer-1 group (1.0 μmol·L⁻¹ Fer-1 and 15% TXD serum) to elucidate the potential association between ferroptosis and ERα proteins. A DCFH-DA probe detected reactive oxygen species (ROS) and Fe²⁺, while Western blotting assessed target protein expression. Both in vitro and in vivo experiments demonstrated that TXD attenuated I/R injury by reducing elevated ST-segment levels, improving cardiac injury biomarkers (LDH, MDA, and SOD), alleviating pathological features, and preventing I/R-induced loss of cell viability in vitro. The effects and mechanisms of TXD on I/R injury-associated ferroptosis were investigated using I/R-induced H9c2 cells. The TXD group showed significantly decreased ROS and Fe²⁺ levels, while the AZ group (treated with AZD9496) exhibited increased levels. The TXD group demonstrated enhanced expression of ERα and glutathione peroxidase 4 (GPX4), with reduced levels of P53 protein and ferritin-heavy polypeptide 1 (FTH1). The AZ group exhibited contrasting effects on these expression levels. The literature indicated a novel connection between ERα and ferroptosis. TXD activates the ERα signaling pathway, promoting protection against I/R-induced myocardial cell ferroptosis. This study provides evidence supporting TXD use for myocardial ischemia treatment, particularly in older female patients who may benefit from its therapeutic outcomes.

Keywords

Tianxiangdan / Estrogen receptor alpha / Ferroptosis / Myocardial ischemia-reperfusion injury / Network pharmacology

References

[1] Pagliaro BR, Cannata F, Stefanini GG, et al. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020; 25(1):53-65. https://doi.org/10.1007/s10741-019-09831-z.

[2] Hu L, Sun Y, Zhang H, et al. Catalpol ameliorates myocardial I/R injury through PI3k/Akt/P53 signaling-mediated anti-autophagy and anti-apoptosis. Pharmacogn Mag. 2023; 19(4):946-953. https://doi.org/10.1177/09731296231189557.

[3] Gibbons RJ. Myocardial ischemia in the management of chronic coronary artery disease: past and present. Circ Cardiovasc Imaging. 2021; 14(1):e011615. https://doi.org/10.1161/CIRCIMAGING.120.011615.

[4] Pratush A, Ye X, Yang Q, et al. Biotransformation strategies for steroid estrogen and androgen pollution. Appl Microbiol Biotechnol. 2020; 104(6):2385-2409. https://doi.org/10.1007/s00253-020-10374-9.

[5] Wilkinson HN, Hardman MJ. The role of estrogen in cutaneous ageing and repair. Maturitas. 2017; 103:60-64. https://doi.org/10.1016/j.maturitas.2017.06.026.

[6] Chen K, Wang S, Sun QW, et al. Klotho deficiency causes heart aging via impairing the Nrf2-GR pathway. Circ Res. 2021; 128(4):492-507. https://doi.org/10.1161/CIRCRESAHA.120.317348.

[7] Deligdisch-Schor L. Hormone therapy effects on the uterus. Adv Exp Med Biol. 2020;1242:145-177.

[8] Jiang L, Yue YJ, Tang M, et al. Mechanism investigation of Tianxiangdan against myocardial ischemia based on network pharmacology, molecular docking, and in vitro experimental. Pharmacogn Mag. 2024; 20(3):784-793. https://doi.org/10.1177/09731296231220992.

[9] Sun LF, An DQ, Niyazi GL, et al. Effects of Tianxiangdan Granule treatment on atherosclerosis via NF-κB and p38 MAPK signaling pathways. Mol Med Rep. 2018; 17(1):1642-1650. https://doi.org/10.3892/mmr.2017.8067.

[10] Wang WW, Liu XL, Ding Y, et al. Scutellarin protects myocardial ischemia-reperfusion injury ERK1/2-CREB regulated mitophagy. Pharmacogn Mag. 2023; 19(4):1021-1036. https://doi.org/10.1177/09731296231199860.

[11] Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022; 82(12):2215-2227. https://doi.org/10.1016/j.molcel.2022.03.022.

[12] Sophocleous A, Idris AI. Ovariectomy/orchiectomy in rodents. Methods Mol Biol. 2019; 1914:261-267. https://doi.org/10.1007/978-1-4939-8997-3_13.

[13] Zhao W, Wu Y, Ye F, et al. Tetrandrine ameliorates myocardial ischemia reperfusion injury through miR-202-5p/TRPV2. Biomed Res Int. 2021;2021:8870674. https://doi.org/10.1155/2021/8870674.

[14] Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836. https://doi.org/10.1155/2019/8151836.

[15] Tang D, Wang C, Gan Q, et al. Chemical composition-based characterization of the anti-allergic effect of Guominkang Formula on IgE-mediated mast cells activation and passive cutaneous anaphylaxis. Chin J Nat Med. 2022; 20(12):925-936. https://doi.org/10.1016/S1875-5364(22)60225-5.

[16] Xia H, Zhang JF, Wang LY, et al. Bioactive neolignans and lignans from the roots of Paeonia lactiflora. Chin J Nat Med. 2022; 20(3):210-214. https://doi.org/10.1016/S1875-5364(22)60164-X.

[17] Hayıroğlu M, Lakhani I, Tse G, et al. In-hospital prognostic value of electrocardiographic parameters other than ST-segment changes in acute myocardial infarction: literature review and future perspectives. Heart Lung Circ. 2020; 29(11):1603-1612. https://doi.org/10.1016/j.hlc.2020.04.011.

[18] Yan HF, Tuo QZ, Yin QZ, et al. The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res. 2020; 41(3):220-230. https://doi.org/10.24272/j.issn.2095-8137.2020.042.

[19] Liam CCK, Tiao JY, Yap YY, et al. Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH). Blood Res. 2023; 58(1):36-41. https://doi.org/10.5045/br.2023.2022133.

[20] Gerbarg PL, Brown RP. Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine. 2016; 23(7):763-769. https://doi.org/10.1016/j.phymed.2015.11.013.

[21] Li Z, Liu M, Chen M, et al. Clinical effect of Danshen Decoction in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2023; 18(5):e0284877. https://doi.org/10.1371/journal.pone.0284877.

[22] Whaley AO, Ivkin DY, Zhaparkulova KA, et al. Chemical composition and cardiotropic activity of Ziziphora clinopodioides subsp. bungeana (Juz.) Rech. f. J Ethnopharmacol. 2023;315:116660. https://doi.org/10.1016/j.jep.2023.116660.

[23] Chen XF, Li XL, Yang M, et al. Osteoprotective effects of salidroside in ovariectomized mice and diabetic mice. Eur J Pharmacol. 2018; 819:281-288. https://doi.org/10.1016/j.ejphar.2017.12.025.

[24] Zheng H, Qi S, Chen C. Salidroside improves bone histomorphology and prevents bone loss in ovariectomized diabetic rats by upregulating the OPG/RANKL ratio. Molecules. 2018; 23(9):2398. https://doi.org/10.3390/molecules23092398.

[25] Wang C, Yuan W, Hu A, et al. Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury. Mol Med Rep. 2020; 22(1):175-184. https://doi.org/10.3892/mmr.2020.11114.

[26] Liu Y, Shu J, Liu T, et al. Nicorandil protects against coronary microembolization-induced myocardial injury by suppressing cardiomyocyte pyroptosis via the AMPK/TXNIP/NLRP3 signaling pathway. Eur J Pharmacol. 2022;936:175365. https://doi.org/10.1016/j.ejphar.2022.175365.

[27] Pálóczi J, Paál Á, Pigler J, et al. Organ-specific model of simulated ischemia/reperfusion and hyperglycemia based on engineered heart tissue. Vascul Pharmacol. 2023;152:107208. https://doi.org/10.1016/j.vph.2023.107208.

[28] Yang L, Wang H, Yang X, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020; 5(1):138. https://doi.org/10.1038/s41392-020-00253-0.

[29] Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1-2):317-331. https://doi.org/10.1016/j.cell.2013.12.010.

[30] Kim HS, Seo JY, Park NG. Material and device stability in perovskite solar cells. ChemSusChem. 2016; 9(18):2528-2540. https://doi.org/10.1002/cssc.201600915.

[31] Liang D, Feng Y, Zandkarimi F, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023; 186(13):2748-2764.e2722. https://doi.org/10.1016/j.cell.2023.05.003.

[32] Bai Y, Wang W, Wang L, et al. Obacunone attenuates liver fibrosis with enhancing anti-oxidant effects of GPx-4 and inhibition of EMT. Molecules. 2021; 26(2):318. https://doi.org/10.3390/molecules26020318.

[33] Dang R, Wang M, Li X, et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway. J Neuroinflammation. 2022; 19(1):41. https://doi.org/10.1186/s12974-022-02400-6.